BACKGROUND: The red blood cell (RBC) endothelial nitric oxide synthase (eNOS) has been shown to regulate intrinsic RBC rheologic properties, such as membrane deformability, suggesting that a functional eNOS could be important in RBC viability and function during storage. This study examines the correlation between RBC eNOS deficiency and the propensity of RBCs to hemolyze under selected stress conditions including prolonged hypothermic storage. STUDY DESIGN AND METHODS: Fresh or stored RBCs from normal and eNOS knockout (KO) mice or from healthy human volunteers were subjected to selected hemolytic stress conditions including mechanical stress hemolysis, osmotic stress hemolysis, and oxidation stress hemolysis and evaluated during standard storage in CPDA-1 solutions. RESULTS: Fresh RBCs from normal and eNOS KO mice demonstrated comparable susceptibility to hemolysis triggered by mechanical stress (mechanical fragility index 6.5 ± 0.5 in eNOS KO vs. 6.4 ± 0.4 for controls; n = 8-9), osmotic stress, and oxidative stress. Additionally, RBCs from both mouse groups exhibited similar hemolytic profile at the end of 14-day hypothermic storage, analogous to 42 days of human RBC storage. Storage of human RBCs (28 days in CPDA-1) in the presence of NOS cofactors (L-arginine and tetrahydro-L-biopterin) or inhibitor (N(5) -[imino(methylamino)methyl]-L-ornithine monoacetate) did not affect cell recovery or hemolytic response to the selected stressors. CONCLUSION: These studies suggest that RBC eNOS does not modulate susceptibility to hemolysis in response to selected stress conditions or prolonged hypothermic storage. Other strategies to increase nitric oxide (NO) bioactivity after prolonged storage utilizing NOS-independent pathways such as the nitrate-nitrite-NO pathway may prove a more promising approach.
BACKGROUND: The red blood cell (RBC) endothelial nitric oxide synthase (eNOS) has been shown to regulate intrinsic RBC rheologic properties, such as membrane deformability, suggesting that a functional eNOS could be important in RBC viability and function during storage. This study examines the correlation between RBC eNOS deficiency and the propensity of RBCs to hemolyze under selected stress conditions including prolonged hypothermic storage. STUDY DESIGN AND METHODS: Fresh or stored RBCs from normal and eNOS knockout (KO) mice or from healthy human volunteers were subjected to selected hemolytic stress conditions including mechanical stress hemolysis, osmotic stress hemolysis, and oxidation stress hemolysis and evaluated during standard storage in CPDA-1 solutions. RESULTS: Fresh RBCs from normal and eNOS KO mice demonstrated comparable susceptibility to hemolysis triggered by mechanical stress (mechanical fragility index 6.5 ± 0.5 in eNOS KO vs. 6.4 ± 0.4 for controls; n = 8-9), osmotic stress, and oxidative stress. Additionally, RBCs from both mouse groups exhibited similar hemolytic profile at the end of 14-day hypothermic storage, analogous to 42 days of human RBC storage. Storage of human RBCs (28 days in CPDA-1) in the presence of NOS cofactors (L-arginine and tetrahydro-L-biopterin) or inhibitor (N(5) -[imino(methylamino)methyl]-L-ornithine monoacetate) did not affect cell recovery or hemolytic response to the selected stressors. CONCLUSION: These studies suggest that RBC eNOS does not modulate susceptibility to hemolysis in response to selected stress conditions or prolonged hypothermic storage. Other strategies to increase nitric oxide (NO) bioactivity after prolonged storage utilizing NOS-independent pathways such as the nitrate-nitrite-NO pathway may prove a more promising approach.
Authors: Binglan Yu; Mohd Shahid; Elena M Egorina; Mikhail A Sovershaev; Michael J Raher; Chong Lei; Mei X Wu; Kenneth D Bloch; Warren M Zapol Journal: Anesthesiology Date: 2010-03 Impact factor: 7.892
Authors: James D Reynolds; Gregory S Ahearn; Michael Angelo; Jian Zhang; Fred Cobb; Jonathan S Stamler Journal: Proc Natl Acad Sci U S A Date: 2007-10-11 Impact factor: 11.205
Authors: Binglan Yu; Michael J Raher; Gian Paolo Volpato; Kenneth D Bloch; Fumito Ichinose; Warren M Zapol Journal: Circulation Date: 2008-04-07 Impact factor: 29.690
Authors: Marion C Lanteri; Tamir Kanias; Sheila Keating; Mars Stone; Yuelong Guo; Grier P Page; Donald J Brambilla; Stacy M Endres-Dighe; Alan E Mast; Walter Bialkowski; Pam D'Andrea; Ritchard G Cable; Bryan R Spencer; Darrell J Triulzi; Edward L Murphy; Steven Kleinman; Mark T Gladwin; Michael P Busch Journal: Transfusion Date: 2018-11-08 Impact factor: 3.157
Authors: John D Roback; Cassandra D Josephson; Edmund K Waller; James L Newman; Sulaiman Karatela; Karan Uppal; Dean P Jones; James C Zimring; Larry J Dumont Journal: Transfus Med Rev Date: 2014-02-05
Authors: Tamir Kanias; Derek Sinchar; David Osei-Hwedieh; Jeffrey J Baust; Andrew Jordan; James C Zimring; Hayley R Waterman; Karen S de Wolski; Jason P Acker; Mark T Gladwin Journal: Transfusion Date: 2016-08-09 Impact factor: 3.157
Authors: Lorenzo Bertolone; Hye Kyung H Shin; Jin Hyen Baek; Yamei Gao; Steven L Spitalnik; Paul W Buehler; Angelo D'Alessandro Journal: Front Physiol Date: 2022-03-21 Impact factor: 4.566
Authors: Lorenzo Bertolone; Hye K Shin; Davide Stefanoni; Jin Hyen Baek; Yamei Gao; Evan J Morrison; Travis Nemkov; Tiffany Thomas; Richard O Francis; Eldad A Hod; James C Zimring; Tatsuro Yoshida; Matthew Karafin; Joseph Schwartz; Krystalyn E Hudson; Steven L Spitalnik; Paul W Buehler; Angelo D'Alessandro Journal: Front Physiol Date: 2020-10-23 Impact factor: 4.566